Last reviewed · How we verify
NCT03975023
Investigating Event-Related Potentials and Eye-Tracking Measures in Hockey Players
trial testing NeuroCatch Platform (NCP) in Healthy in 52 participants. Completed in 16 April 2020.
11 July 2019
Quick facts
| Lead sponsor | Frederick Carrick, PhD, FACCN |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 52 |
| Start date | 7 July 2019 |
| Primary completion | 11 July 2019 |
| Estimated completion | 16 April 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- NeuroCatch Platform (NCP)
Conditions studied
- Healthy — all drugs for Healthy →
- Traumatic Brain Injury — all drugs for Traumatic Brain Injury →
Sponsor
Frederick Carrick, PhD, FACCN
Who can join
Adults 14 to 25, any sex, with Healthy or Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Traumatic brain injury (TBI) is a health issue impacting athletes and no clinical treatment protocol, other than rest, is yet established. The efficacy of a treatment protocol relies on objective, physiological measures of brain function and ultimately a quantification of injury severity. The present study aims to assess neurophysiological markers of auditory and visual measures of brain function using the NeuroCatch Platform and eye-tracking technology, respectively. The current gold standard of TBI evaluation, including cognitive and balance assessments, will also be captured.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Brain Vital Signs in Elite Ice Hockey: Towards Characterizing Objective and Specific Neurophysiological Reference Values for Concussion Management.
Carrick FR, Pagnacco G, Azzolino SF, Hunfalvay M, et al · · 2021 · cited 8× · PMID 34434084 · DOI 10.3389/fnins.2021.670563
Verify or expand the search:
- PubMed search for NCT03975023
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03975023 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Frederick Carrick, PhD, FACCN
- Last refreshed: 27 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03975023.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing